Trends in the costs of drugs launched in the UK between 1981 and 2015: an analysis of the launch price of drugs in five disease areas.

ABSTRACT:

Objectives

To investigate the trend in the launch price of new drugs for five common health conditions.

Design

Cross-sectional study using data on new drugs launched in the UK between 1981 and 2015 for hypertension, asthma, rheumatoid arthritis, schizophrenia and colorectal cancer.

Data and sources

All drugs marketed in the UK between 1981 and 2015 (inclusive), and licensed specifically for the treatment of one of the five chosen conditions were included in the study. Newly launched medicines and their launch prices were identified by hand-searching all editions of the British National Formulary in addition to searching the websites of relevant regulatory agencies (European Medicines Agency and Medicines and Healthcare products Regulatory Agency). The launch price in

SUBMITTER: Ward DJ 

PROVIDER: S-EPMC6501986 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature